epidemiological triad
host: discerns its surroundings & responds to changes
pathogen: decrease or increase in virulence
environment: friendly changes (temperature, nutrients) or detrimental changes (cold, lack of food, irradiation)
—>coexistance or disease
—>neuronal circuits detect pain & temperature alterations
—>immune pathway detect microbial encounters and tissue injury
innate immune response
macrophages
epithelial cells
neutrophils
innate lymphoid cells
starts after minutes and ends after days
adaptive immune response
B- & T-lymphocytes
starts after 12-24 hours and lasts for weeks
bridged to innate immune response by dendritic cells
Pattern Recognition Receptors PRR
receptors of the innate immune response
limited number (10 TLR, 22 NLR)
germline-encoded
ligand present of non-self (conserved and invariant microbial motifs) MAMP, PAMP & non-pathogen associated molecular patterns but also on seld (alarmins) & DAMP
expressed on DC, neutrophils, macrophages, B-cells & endothelial & epithelial cells (exposed to microbes in mucus membrane)
types of PRR
free receptor
membrane-bound phagocytic receptors
membrane-bound signaling receptors
cytosolic signaling receptors
free receptors
in serum and extracellular fluids
C1q molecule of the classical pathway of the complement system
collectins: Mannose-Binding Lectins (MBL) & Surfactant Protein A&D (SP-A & SP-D)
ficolins
pentraxins
Membrane-bound phagocytic receptors
involved in phagocytosis of extracellular pathogens —> initiation of phagocytosis
opsonin receptors: CR, Fc receptors
mannose receptor (mannosylated ligands present on virus, bacteria & fungi)
dectin: glucans—>polymers of glucose on fungi
scavenger receptors: SR-AI/II, MARCO & CD36 (lipids, lipoproteins of bacteria)
expressed by DC, macrophages, neutrophil & B-cell
detect extracellular and endosomal pathogen—>initiation of inflammatory chemokine & cytokine synthesis
Toll-like receptors (with LRR domain)
expressed by DC, neutrophil, macrophage & epithelial cell
PAMPs detected: extracellular & endosomal microbial compounds
detect intracellular pathogens —> initiation of inflammatory chemokine & cytokine synthesis & pyroptosis (a particular type of cell death)
NLR: nucleotide-binding domain NBD and Leucine-rich repeat LRR receptor or NOD-like receptor
RLR: RIG1 helicase (retinoicacid inducible gene)-like receptor)
ALR: absent in melanoma 2-like receptors
expressed by nearly all cell types
PAMPs detected: cytoplasmic microbial compounds & alarmins
Cellular localization of PRR
all compartments are equipped with several PRR
cell surface: TLR recognizes extracellular pathogens (bacteria, fungi, or viruses)
endosome: TLR recognizes endocytosed invaders
cytoplasm: NLR/RLR/ALR—>cytosolic microbes necessarily virulent pathogens
no receptor described in the nucleus
Gram-positive bacteria
cell membrane & peptidoglycan
Gram-negative bacteria
cell membrane, thin peptidoglycan & outer membrane with lipopolysaccharide
Lipid A
endotoxin
very important part for the inflammatory activity of LPS
anchors LPS in the membrane
has 6 acy-chains for anchoring in outer leaflet
extracellular part with polysaccharides of various öength
Toll mutant
highly sensitive to fungi (Gram+) infections—>Drosophila shows dramatic reduction in survival after infection
mice resistant to LPS due to punctual mutation in the TIR domain of TLR4—>no TNFα produced after stimulation with LPGS (Gram-)
Toll-like receptor family
endosomal TLRs detect DNA/RNA
all detect different ligands of microbes
TLR6/2: parasite (GPI-anchor), yeast (zymonsan). bacteria (Diacyllipopeptides)
TLR1/2: bacteria (Triacyllipopeptides)
TLR4: LPS
TLR5: flagellin
on cell surface
TLR3,7/8,9: in endosome detecting dsRNA, ssRNA (virus) and DNA without CpG (bacteria)
—>limited number of TLR can detect presence of many different microorganisms by recognizing common features that are typical of different groups of pathogens
TLR4 ligands
different PAMPs (LPS, Taxol, fusion protein, Env proteins)
DAMPs (oxidized LDL,…)
endogenous ligands
alarmins
Structure of TLR
extracellular: Leucine-rich repeat LRR containing proteins or Ig domain
membrane anchor: helical transmembrane domain or GPI anchor (CD14)
intracellular: Toll/interleukin-1 TIR superfamily —> high homology
horseshoe or solenoid structure of the LRR domain
20-27 LRR modules constitute the main extracellular part of TLR
each LRR is composed of 20-30 amino acids rich in the hydrophobic amino acid leucine
hydrophobic core (ß-strand), asparagine network & variable region (α-helix or α-helix like)
α-helix convex
ß-sheet concave
C-terminal & N-terminal with Asn ladder
central part more flexible without Asn
binding of the LPS to TLR4/MD2
MD2 (associated with both monomers) binds 5 acyl-chains from LPS
LPS (glycan chains & 1 acyl-chain) binds TLR4
MD2 induces the formation of dimerization of TLR4 due to the binding of the lipopeptide
dimerization of TLR
induced by binding of the ligand (LPS, dsRNA etc)
General mechanism of TLR signalization
dimerization induced by the ligand binding
adaptor protein: Myd88 (universal adaptor) or TRIF
serine threonine kiases
transcription factor translocation in the nuclues
dimerization of TLR4
induced by ligand binding
LPS bound by LPS binding protein LBP (soluble in the serum)
transfer of LPS to GPI-anchor protein (CD14)
transfer of LPS to MD2 bound to TLR4
intracellular signaling after activation of TLR
homodimerization TLR4
2 TIR domains interact with TIR domain of Myd88—>oligomerization of 6 Myd88 (Myddosome)
death domain of Myd88 interacts with IRAK (kinase)
TRAF-6 (E3 ligase) binds Myddosome & self-ubiquitinylation
polyubiquitin allows interaction with TAK1, IKKγ (NEMO) & IKKα/ß
TAK1 gets phosphorylated—> phosphorylation MAP kinase-kinase 4 —> JNK —> AP-1 (activates gene expression)
IKKγ phosphorylation —> IKKß phosphorylation —> proteolysis & release of NFκB —> translocation in nucleus & expression of pro-inflammatory cytokines
also internalization of TLR4 homodimer into endosome —> interacts with TRIF (instead of Myd88)—> other signaling pathway —> TRAF3 phosphorylated —> IRF3 phosphorylation & translocation into IRF3 —> expression of IFN type 1 (α&ß)
myddosome
helical structure & compact structure
all TLR use the same adaptor: Myd88 except endosomal TLR4 & TLR3 which use TRIF adaptor
TLR-induced cytokine expression
TLR3/4/7/8/9 leads to secretion of IL-12 & IFNα
engages differentiation of T helper into Th1
secretion of Il-12, TNFα & IFNγ (against intracellular/bacterial infections)
cell-mediated immunity: B cells produce IgG & IgA
TLR5,2/1,2/6 leads to secretion of Il-10 &-4 by DC—>differentation into Th2
secretion of Il-4, Il-5, Il-10 (parasitic infections, also involved in allergy)
B cells secrete IgE, IgG & IgA
signals for T-cell activation
MHC/peptide/TCR
costimulator: CD80/CD28 or CD86/CD28
cytokines: secreted by DC binding receptors on T-cell
Cell surface expression after PAMP-induced DC maturation
increased expression of HLA-DR & CD80 on all
CD86 not by all ligands increased
gene regulation by LPS/TLR4 or PAM/TLR2
if TLR4 KO: no production of TNFα & RANTES after induction with LPS or Lipid A (ligand TLR4), no impact if Pam2 (ligand of TLR2)
impact on gene regulation: 700-800 genes differently regulated —>huge amount of genes regulated regulated by TLR4 regulation
Effect of TLR signalization on antigen-presenting capabilities of APC
internalized peptides (ligands of TLR) can bind MHCI/ MHCII —>expressed at the surface for interaction with TCR/BCR
also induction of costimulatory molecules & cytokine production & other genes
stimulation via the TLR initiates & modulates the adaptive cellular & humoral immune response
Primary immunodeficiency in the TLR pathways
recurrent pneumococcal meningitis
stroke, seizure, middle-ear infections, intestinal intussusception, perforation, boils
develops low-grade fevers late in the course of illnesses
—>normal complete blood count, complement function & immunoglobulin titers
—>ability to make a protective response against protein antigens but failed to mount a response against polysaccharide antigen
—>significant decrease in TNFα secretion after TLR stimulation
affected molecule in primary immunodeficiency in the TLR pathway
WB for phospho-p38 & phospho-IκBα —>both not present in the patient
—> Sequencing revealed a homozygous nonsense mutation in the kinase domain of IRAK4
—>no downstream signaling
IRAK-4 deficiency
high number of infections in first 40 month (meningitis, septicemia & arthritis)
50% dead before 40 months of life
after 5 years no more problems—> in first period of life innate system with a great role to protect organism, after 5 years adaptive immune system completely functional
MAL deficiency
MAL encoded by TIRAP
impairs cellular responses to TLR2 & TLR4 stimulation
causes staphylococcal disease
Anti-LTA antibodies rescue TLR2-dependent responses to LTA in TIRAP-deficient cells
—>compensates absence of TIRAP
—>adaptive immune response can compensate for deficiency in the TLR pathway
TLR polymorphism
TLR encoding genes are extremely polymorphic
10% of the European population has a mutated allele of TLR5 (homozygous mutation not characterized by severe immunodeficiency —>redundant role)
adaptive evolution (infections) & nonadaptive evolution (genetic drift, population bottlenecks & migration routes) contribute to polymorphisms in various populations
give resistance to infections via sensing of PAMPS but also greater risk of autoimmunity (endogenous ligands acting via PRRs)
Asp299Gly & Thr399Ile in TLR4
common single nucleotide polymorphism
Asp299Gly protects from mortality due to cerebral malaria but also increased risk of septic shock from infection by Gram-negative bacteria
15% in Africa (malaria) lost during migration to Europe, not prevalent in South America
removal of intracellular pathogens
CTL: granzyme & perforin activate apoptotic cell death
NK
phagocytic cells
type I Interferon (α & ß): inhibit viral replication
Il-1ß & Il-18 —> key mediator of inflammatory response—>cleaved from pro-peptide by activation of caspase 1 (also induces pyroptosis)
Pyroptosis
cell death mechanism
characterized by cell swelling, lysis & release of cytoplasmic content
Inflammasome
Multi-protein complexes that activate caspase 1 to induce processing of pro-interleukin-1ß & pro-interleukin 18 and to drive pyroptosis
—>cell autonomous immunity
central signaling hub regulating innate immunity
visualization of inflammasomes
speck in fluorescence & confocal microscopy
intracellular pathogen detection
PAMP or DAMP (self: ATP, MSU, CPPD, amyloid-ß; or non-self: asbestos, silica, alum)
classical signaling pathway (NOD1, NOD2)—>NFκB IRF —>TNF, Il-6, IFN type 1 —-> regulation of transcription
inflammasome signaling pathway (NLRP1, NLRC4, AIM2)—> cytosolic platform (oligomerization of the sensor) —>caspase 1 activation —>Il-1 & Il-18 (from pro-peptides) & pyroptosis —> post-transcriptional effects
intracytoplasmic PRR with the ability to form the inflammasome platform
NLRC4
NLRP1, NLRP3
NAIP1, NAIP2, NAIP5/6
AIM2
NLR family
ancestral nucleotide-binding domains (NBDs)
NLR present in animals & plants
similar number in mouse (30) & human (22)
no TLR in Drosophila (use other PRR)
structure NLR
around 1000 AA
N-terminal domain, functional domain, or homotypic interaction domain (150 AA), differ
NACHT or NOD oligomerization domain (500 AA)
LRR ligand binding domain (300 AA), TLR common structure
major NLR
NLRP1B: activated by Bacillus anthracis (secretes Anthrax proteins into phagolysosome) & T. gondii (also secretes protease) —> protease cleaves NLRP1B —>activates oligomerization
NLRP3: activated by diverse stimuli that might damage cellular membranes (pore formation) —>e.g. ATP (only extracellular after cell lysis) —> unknown endogenous signal induces the formation of the inflammasome by oligomerization of NLRP3
NLRC4: activated by flagellin & different proteins of the T3SS of bacteria (e.g. Salmonella) —> sensed by NAIP protein —> interacts with ligand & NLRC4 —> oligomerization
all lead to activation of caspase 1 cleaving pro-Il1ß / 18 & gasdermin D (N-terminal fragment induces pyroptosis)
pro-Il-1 & pro-Il-18
first signal required to induce their production
not constitutively expressed
need TLR4 signal for their expression
latent factors
components of the inflammasome
trigger: T3SS proteins (in NAIP-NLRC4)
sensor: self-proteins detecting the sensor having a NACHT & BIR domain (NIAP)
nucleator: oligomerizes to form inflammasome, has NACHT & CARD domain (NLRC4)
adaptor: links nucleator & effector (ASC)
effector: function to proteolyse gasdermin & pro-cytokines (caspase 1)
transition inactive & active conformation of NAIP5
ligand binding (flagellin) leads to the opening of the molecule—>LRR released from the central NACHT domain
wheel-like structure of Fla-NAIP5-NLRC4 complex
opening of NAIP exposes nucleating surface (basic)
interacts with the acidic surface of NLRC & its opening (exposure of LRR) & newly formed nucleating surface (basic)
self-propagating oligomerization
fully formed wheel-like structure consists of 11 NLRC4 molecules & 1 NAIP2
Caspase 1 activation
CARD domain of NLRC allows interaction with the adaptor protein ASC
ASC polymerization by homotypic interaction of their PYD domains & CARD domains of fiber protrude outside (high number of fibers leads to speck=
followed by caspase-1 recruition (via CARD) —>pro-caspase closer —> auto-activation to heterotetramer (2 p20 & 2 p10 domains)
active caspase 1 leads to release of Il-1ß & Il-18 from pores formed by gasdermin N-terminal fragment (also cleaved by caspase 1) & induces also pyroptosis
effect of gasdermin D
doesn’t always lead to cell death
membrane repair process can eliminate pore —> activation of inflammasome not automatically death
regulation of the adaptive immune system by the inflammasome
inflammasome-mediated cleavage of cytokines
inhibition Il-33 production —> no Th2 polarization
IFNγ production, Th17 differentiation, T-cell proliferation & Il-17 production
Non-canonical inflammasomes
don’t use NLR and caspase-1
Immune dysregulation in inflammatory diseases connected to inflammasomes
Il-1ß has a major role in inflammation
in some pathologies, inflammasome is constantly activated in the absence of a ligand
—>cyropryinopathies, familial Mediterranean fever, macrophage-activating syndrome (life-threatening, recurrent fever, hepatobiliary dysfunction, coagulopathy, low peripherical cell counts)
clinical manifestations if Il-1 mediated diseases
inflammatory symptoms affect CNS, muscles, eyes & pulmonary skeletal muscles
NLRC4 mutation
causes syndrome of enterocolitis & autoinflammation
mutation in NACHT domain (normally interacting in inactive state with LRR) but constantly open due to mutation
increased cell lysis & cytokine production
serious pathologies
action of adjuvants
inflammasome activated by alum (present in 50% of vaccines)
coronaviruses
respiratory infectious disease due to coronavirus-2
common human coronaviruses (common cold)
dangerous human coronaviruses (SARS-CoV & MERS-CoV)
SARS-CoV2 origin
three viruses in bats with 95% shared overall genome
direct passage to human or through pangolines
cell entrance SARS-CoV2
S protein binds ACE2 (Angiotensin Conversion Enzyme 2) which is present in many different cells (lungs, heart, kidney, liver —>many different syndroms)
cleaved by TMPRSS2 (Transmembrane Protease Serine 2)
Symptoms SARS-CoV2
30-40% asymptomatic
60-70% symptomatic
—>80% mild (runny nose & dry cough, low grade fever)
—>15% severe: fluid in lungs, decreased blood oxygen (oxygenation with mask)
—>5% critical: organ failure due to lack of oxygen, inflammation & septic shock (oxygenation by intubation & anesthesia)
Co-morbidities SARS-CoV2
obesity
diabetes
heart dieases
hypertension
aging (90% of death over 65 years old)
treatment of SARS-CoV2
vaccines
protease inhibitor
nucleoside analogs
anti-inflammatory molecule JAK1/2 inhibitor
cytokine inhibition with anti-Il-6 antibodies
link inflammatory symptoms & innate immunity
inappropriate hyperinflammatory responses important
co-morbidities associated with high basal inflammation
PRR involved in sensing
MDA & RIG-1 are RLR
TLR2 senses E protein (secretion proinflammatory cytokines)
TLR4 probably senses S protein (sequence analysis)
link inflammatory symptoms & inflammasomes
elevated serum LDH (lactate dehydrogenase) concentration strongest single predictor of severe covid
Il-1ß & Il-18 also highly predictive biomarker of death in Covid patients
Il-1ß controls production of Il-6/TNF
Innate immune evasion by SARS-CoV2
molecules to escape detection by signaling proteins
inhibition TLR2&4
inhibit translocation —>no antiviral response
innate immune response to SARS-CoV2
cytokine storm —>hyperactivity
Zuletzt geändertvor 9 Monaten